Research Facility

Nashville, Tennessee 37232

We've found

1 trials

at this facility

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Nashville, TN

Use our guide to learn which trials are right for you!